|
Variable
|
No AKI (n = 91)
|
AKI (n = 38)
|
P value
|
|---|
|
SAPS 3
|
67 ± 15
|
68 ± 14
|
0.63
|
|
Age, yrs
|
60.8 ± 14.6
|
62.6 ± 15.9
|
0.53
|
|
Weight, kg
|
70.5 ± 15.2
|
77.3 ± 15.0
|
0.02*
|
|
Gender, % male
|
51.6
|
60.5
| |
|
Concomitant medication
| | | |
|
Aminoglycosides, n (%)
|
39 (43)
|
12 (32)
|
0.32
|
|
ACEi or AT-IIra, n (%)
|
17 (19)
|
7 (18)
|
1
|
|
NSAIDs, n (%)
|
4 (4)
|
1 (3)
|
1
|
|
Immunosuppressants, n (%)
|
2 (2)
|
0 (0)
|
1
|
|
Comorbidities
| | | |
|
Diabetes, n (%)
|
49 (54)
|
30 (79)
|
0.01*
|
|
Shock, n (%)
|
54 (59)
|
33 (87)
|
0.002*
|
- AKI = acute kidney injury; SAPS = Simplified Acute Physiology Score; ACEi = angiotensin converting enzyme inhibitors; AT-IIra = angiotensin-II receptor antagonists; NSAIDs = non steroidal anti-inflammatory drugs
- * P level < 0,05 is considered significant
